Immunohistochemistry and qPCR analyses also revealed elevated CB2R/ Cb2r expression in the liver from MPS IIIA mice, evident by 2 months of age and highly significant by 10 months (Figure 3A ).
← all excerpts
Endocannabinoid receptor 2 is a potential biomarker and therapeutic target for the lysosomal storage disorders.
1
—
—